Efficacy and Safety of Hydrolyzed Ginseng Extract on Impaired Fasting Glucose
- Conditions
- Hyperglycemia
- Interventions
- Dietary Supplement: HGE (hydrolyzed ginseng extract)Dietary Supplement: Placebo
- Registration Number
- NCT01854164
- Lead Sponsor
- Chonbuk National University Hospital
- Brief Summary
This study was conducted to investigate the effects of daily supplementation of hydrolyzed ginseng extract(HGE) on glycemic status in subjects with impaired fasting glucose(IFG).
- Detailed Description
This study was a 8 weeks, randomized, double-blind, placebo-controlled trial. Twenty subjects were randomly divided into HGE or a placebo group. Fasting and postprandial glucose profiles during oral glucose tolerance test (OGTT) were assessed before and after the intervention.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
- Age 20-70 years with fasting glucose 100~126 mg/dL
- Abnormal lipid profile values
- Acute/chronic inflammation
- Treated with corticosteroid within past 4 weeks
- Cardiovascular disease
- Allergic or hypersensitive to any of the ingredients in the test products
- History of disease that could interfere with the test products or impede their absorption
- Participation in any other clinical trials within past 2 months
- Renal disease
- Abnormal hepatic function
- Under hypolipidemic drugs therapy within past 3 months
- Under antipsychotic drugs therapy within past 2 months
- Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
- History of alcohol or substance abuse
- Pregnancy or breast feeding
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description HGE(hydrolyzed ginseng extract) HGE (hydrolyzed ginseng extract) HGE capsules(2cap/d, 960mg/d) for 8 weeks. Placebo Placebo Placebo for 8 weeks
- Primary Outcome Measures
Name Time Method Changes of blood glucose during OGTT(oral glucose tolerance test) 8 weeks Changes of fasting and postprandial glucose during OGTT were assessed before(baseline) and after the intervention.
- Secondary Outcome Measures
Name Time Method Changes of blood insulin during OGTT. 8 weeks Changes of blood insulin during OGTT were assessed before(baseline) and after the intervention.
Changes of glycated albumin, fructosamine, and lipid profile 8 weeks Changes of glycated albumin, fructosamine, and lipid profile were assessed before(baseline) and after the intervention
Trial Locations
- Locations (1)
Clinical Trial Center for Functional Foods, Chonbuk National University Hospital
🇰🇷Jeonju, Jeollabuk-do, Korea, Republic of